http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102076326-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2009-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102076326-B |
| titleOfInvention | The compositions for the treatment of multiple sclerosis and method |
| abstract | Provide the fluid (being rich in the electrical fluid of gas) of electronic change, comprise the deionized water solution of the oxygen-containing nanostructure of the charge stable of the amount being enough to the adjustment that at least one in cell membrane potential and cell membrane electrical conductivity is provided, additionally provide the therapeutic composition and method that are used for the treatment of inflammatory neurodegenerative disorders or disease or its at least one symptom.The fluid of described electronic change or therapeutic composition and method comprise the ion aqueous fluids of the electronic change of optional and combination with other therapeutic agents.Particular aspects provides by being connected in adjustment cell membrane, transmembrane potential, memebrane protein such as membrane receptor (including but not limited to g protein coupled receptor (GPCR)) and cell (such as, compact siro spinning technology, recessed bond ing, stick district and desmosome), and middle at least one regulates or adjusts the intracellular signal transduction relevant to described inflammatory response.Other embodiments comprise the fluid (such as, the fluid being rich in gas of electronic change and solution) of electronic change and the particular route of administration of therapeutic combination or preparation. |
| priorityDate | 2008-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1479.